The company has positioned BugSpeaks as a non-diagnostic, wellness-focused test, rather than a tool for diagnosing or ...

The future is unlikely to be a choice between doctors and AI, but rather a closer integration of clinical expertise and ...

Kaisha Pharma has established Kaisha Pharma International in Italy as its global business development and customer support hub. The move marks latest step in the company’s strategy to build an ...

Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device ...

Onyx Scientific, a global small molecule contract development and manufacturing organisation (CDMO), is investing more than ...

Superluminal Medicines has raised $60 million in an oversubscribed Series B financing as the biotech moves to take its lead ...

Neuland Laboratories Limited has announced that its Board of Directors approved a capital expenditure of Rs.126 crores for ...

Novartis India Limited has acquired the exclusive rights to promote and distribute NHPL's retina portfolio across India ...

The partnership expands Tech Mahindra’s healthcare and life sciences business in North America and strengthens its ...

FibroBiologics has secured a new US patent covering the use of fibroblasts and fibroblast-derived materials to accelerate ...

AstraZeneca and Daiichi Sankyo’s Enhertu in combination with pertuzumab has secured European Union approval as a first-line ...

The acquired portfolio includes Minipress XL (prazosin), a medication primarily prescribed in India to treat hypertension and ...